Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Opdualag Approved to Treat Advanced Melanoma - NCI

Nivolumab (Opdivo) Drug Information

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study - ScienceDirect

OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Efficacy in Metastatic Melanoma

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity, Journal for ImmunoTherapy of Cancer

Perspective on the Use of Nivolumab Combined with Ipilimumab For Advanced Melanoma

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study - European Journal of Cancer

Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma

Full article: Efficacy and safety of the combined use of ipilimumab and nivolumab for melanoma patients with brain metastases: a systematic review and meta-analysis

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence